Clinical Trials Directory

Trials / Completed

CompletedNCT04167891

Comparison of Scores for Early Brain Damage Assessment at Intensive Care Unit Admission After Out of Hospital Cardiac Arrest

Status
Completed
Phase
Study type
Observational
Enrollment
1,144 (actual)
Sponsor
AfterROSC · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Even in patients with successful return of spontaneous circulation (ROSC), outcome after cardiac arrest remains poor. The overall in-hospital survival rate widely varies both worldwide and across communities, from 1 to 4 folds according to circumstances of arrest and post-resuscitation interventions. Several studies have already shown that early interventions performed after ROSC, such as treatment of the cause, targeted temperature management, optimal hemodynamic management and extra-corporeal life support in selected patients, could improve the outcome in post-cardiac arrest patients. However, the decision process regarding the allocation of these resources, in parallel with the management of patients' proxies, remains a complex challenge for physicians facing these situations. Consequently, several prediction models and scores have been developed in order to stratify the risk of unfavorable outcome and to discriminate the best candidates for post-resuscitation interventions. Overall, several scores exist, but external validation are lacking and direct comparisons are needed to assess relative interest of scoring systems. Indeed, establishing the optimal scoring system is crucial, for optimal treatment allocation and appropriate information to relatives.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCalculation of early prognosis scoreEarly prognosis score will be calculated at intensive care unit admission for each patient based on clinical and biological values as required

Timeline

Start date
2020-08-01
Primary completion
2022-06-30
Completion
2023-09-01
First posted
2019-11-19
Last updated
2024-09-26

Locations

27 sites across 2 countries: Belgium, France

Source: ClinicalTrials.gov record NCT04167891. Inclusion in this directory is not an endorsement.